참고문헌 (46)

1. Korea Central Cancer Registry. Annual report of cancer statistics in Korea in 2018; 2021. 

2. Park JY, Jang SH. Epidemiology of Lung Cancer in Korea: Recent trends. Tuberculosis and Respiratory Diseases. 2016;79(2):58-69. 

   원문보기 상세보기

3. Papadopoulos A, Guida F, LeffondrL K, CLnLe S, Cyr D, Schmaus A, et al. Heavy smoking and lung cancer: Are women at higher risk? Result of the ICARE study. Brt J Cancer. 2014;110:1385-91. 

   상세보기

4. McLean AEB, Barnes DJ, Troy LK. Diagnosing lung cancer: The complexities of obtaining a tissue diagnosis in the era of minimally invasive and personalised medicine. J Clin Med. 2018;7(7):163. 

   상세보기

5. RiihimLki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86(1):78-84. 

   상세보기

6. Conti M, Bendriem B. The new opportunities for high time resolution clinical TOF PET. Clin Trans Img. 2019;7(2):139-47. 

   상세보기

7. Erdi YE. Limits of tumor detectability in nuclear medicine and PET. Mol Img Radionucl Ther. 2012;21(1):23-8. 

   상세보기

8. Qu X, Huang X, Yan W, Wu L, Dai K. A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol. 2012;81(5):1007-15. 

   상세보기

9. Lee SJ, Seo HJ, Cheon GJ, Kim JH, Kim EE, Kang KW, et al. Usefulness of integrated PET/MRI in head and neck cancer: A preliminary study. Nucl Med Mol Imaging. 2014;48(2):98-105. 

   상세보기

10. Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, et al. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Hell J Nucl Med. 2016;19(3):254-68. 

    상세보기

11. Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, et al. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017;46(5):1247-62. 

    상세보기

12. Kwon HW, Becker AK, Goo JM, Cheon GJ. FDG Whole-Body PET/MRI in Oncology: A systematic review. Nucl Med Mol Imaging. 2017;51(1):22-31. 

    상세보기

13. Delso G, Ziegler S. PET/MRI system design. Eur J Nucl Med and Mol Imaging. 2009;36:86-92. 

    상세보기

14. Jung JH, Choi Y, Im KC. PET/MRI: Technical challenges and recent advances. Nucl Med Mol Imaging. 2016;50(1):3-12. 

    상세보기

15. Loeffelbein DJ, Souvatzoglou M, Wankerl V, Martinez-MLller A, Dinges J, Schwaiger M, et al. PET-MRI fusion in head and neck oncology: Current status and implications for hybrid PET/MRI. J Oral Maxillofac Surg. 2012;70(2):473-83. 

    상세보기

16. Nensa F, Beiderwellen K, Heusch P, Wetter A. Clinical applications of PET/MRI: current status and future perspectives. Diagn Interv Radiol. 2014; 20(5):438-47. 

    상세보기

17. Duan XY, Wang W, Li M, Li Y, Guo YM. Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma. Braz J Med Biol Res. 2015;48(3):267-72. 

    상세보기

18. BLsing KA, SchLnberg SO, Brade J, Wasser K. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT. Nucl Med Biol. 2013;40:206-13. 

    상세보기

19. Malladi A, Viner M, Jackson T, Mercier G, Subramaniam RM. PET/CT mediastinal and liver FDG uptake: Effects of biological and procedural factors. J Med Imaging Radiat Oncol. 2013;57:169-75. 

    상세보기

20. Kim MY. Relationship between pSUV of 18F-FDG PET/CT and pathological diagnosis in breast cancer. Journal of Radiological Science and Technology. 2013:36(4);305-11. 

21. Martinez-Moller A, Souvatzoglou M. Tissue classification as a potential approach for attenuation correction in whole-body PET-MRI. J Nucl Med. 2009;50:520-6. 

    상세보기

22. Catana C, Van der Kouwe A, Benner T, Michel CJ. Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med. 2010;51:1431-8. 

    상세보기

23. Soongsathitanon S, Masa-Ah P, Tuntawiroon M. A new standardized uptake values (SUV) calculation based on pixel intensity values. Math Comput Simul. 2012;6:26-33. 

24. Franklin WA, Aisner DL, Davies KD. Pathology, biomarkers, and molecular diagnostics. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE (eds) Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:Chap 15. 

25. Jain S, Pincus MR, Bluth MH, McPherson RA, Bowne WB, Lee P. Diagnosis and management of cancer using serologic and other body fluid markers. In: McPherson RA, Pincus MR (eds) Henry's Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. St Louis, MO: Elsevier; 2017:Chap 74. 

26. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med. 2004;45(9):1519-27. 

    상세보기

27. Kim JE, Kim JS, Choi NG, Han JB. Evaluation of the liver cancer diagnosis function of PET-MRI based on decision matrix analysis. J Kor Cont Asc. 2017;17(11):50-9. 

    원문보기 상세보기

28. Kang GW, Kim SE, Lee DS, Jeong JK. Koh's nuclear medicine. Kor Med. 2008;(3):8-20. 

29. Hutton BF, Erlandsson K, Thielemans K. Advances in clinical molecular imaging instrumentation. Clin Transl Imaging. 2018;6:31-5. 

    상세보기

30. Cangemi V, Volpino P, Drudi FM, D'Andrea N, Cangemi R, Piat G. Assessment of the accuracy of diagnostic chest CT scanning. Impact on lung cancer management. Int Surg. 1996;81(1):77-82. 

    상세보기

31. Ambrosini V, Nicolini S, Caroli P, Nanni C, Massaro A, Cristina Marzola M, et al. PET/CT imaging in different types of lung cancer: An overview. Eur J Radiol. 2021;81(5):988-1001. 

    상세보기

32. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer. Chest J. 2013;143(5): 211-50. 

33. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: Diagnosis and management. Am Fam Physician. 2007;75(1):56-63. 

    상세보기

34. Rivera MP, Detterbeck F, Mehta AC. Diagnosis of lung cancer* The guidelines. Chest. 2003;123:129-36. 

    상세보기

35. Shin GS, Dong GR. The difference of standardized uptake valueon PET-CT according to change of CT parameters. Journal of Radiological Science and Technology. 2007;30(4):373-9. 

36. Pournazari K, Jahangiri P, Mehdizadeh Seraj S, Khosravi M, Arani L, Torigian D, et al. PET/MRI applications in lung cancer. J Nucl Med. 2018;59(Supplement 1):1157. 

37. Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, et al. PET/MRI versus PET/CT in oncology: A prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl and Mol Img. 2020;47:51-60. 

    상세보기

38. Hartenbach M, Hartenbach S, Bechtloff W, Danz B, Kraft K, Klemenz B, et al. Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: A prospective diagnostic trial. Clin Cancer Res. 2014;20(12):3244-53. 

    상세보기

39. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138-43. 

    상세보기

40. Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, et al. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg. 2007;83(2):419-24. 

    상세보기

41. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32(3):435-9. 

    상세보기

42. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg. 2004;78(3):1004-9. 

    상세보기

43. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: Analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg. 2004;78(1):216-21. 

    상세보기

44. Vickers AJ. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. Am Stat. 2008;62(4):314-20. 

    상세보기

45. Killeen PR. Beyond statistical inference: A decision theory for science. Psychon Bull Rev. 2006;13(4):549-62. 

    상세보기

46. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med. 1990:31(12);1927-32. 

저자의 다른 논문 :

김정수 (4)